Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response.
Teiko.bio's investors include Founders Fund, HOF Capital, Tau Ventures, Civilization Ventures, EPIC Ventures.
Teiko.bio is headquartered in Salt Lake City, United States.
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response.
Teiko.bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Teiko.bio — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/teikobio. Accessed September 30, 2026.
VCBacked. (2025). Teiko.bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/teikobio
{{cite web |title=Teiko.bio — Funding & Investors |url=https://www.vcbacked.co/company/teikobio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated